Evidence map›Paper›PMID 34803940›Full record

ArticleFrontiers in microbiology2021

Glycan Biosynthesis Ability of Gut Microbiota Increased in Primary Hypertension Patients Taking Antihypertension Medications and Potentially Promoted by Macrophage-Adenosine Monophosphate-Activated Protein Kinase.

Shuai Zheng, Chunmei Piao, Yan Liu, Xuxia Liu, Tingting Liu, Xiaoping Zhang, Jingyuan Ren, Yulei Liu, Baoli Zhu, Jie Du

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. The Critical Role ofReviews in cardiovascular medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shuai ZhengBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Chunmei PiaoBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yan LiuBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xuxia LiuBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tingting LiuBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoping ZhangBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jingyuan RenDepartment of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yulei LiuDepartment of Clinic Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Baoli ZhuCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jie DuBeijing Anzhen Hospital, Capital Medical University, Beijing, China.
Beijing Anzhen Hospital · CNSouth China Institute of Collaborative Innovation · CNCapital Medical University · CNInstitute of Microbiology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidences suggest that the gut microbiota have their contributions to the hypertension, but the metagenomic characteristics and potential regulating mechanisms in primary hypertension patients taking antihypertension drugs are not clear yet. We carried out a metagenomic analysis in 30 primary hypertension patients taking antihypertension medications and eight healthy adults without any medication. We found that bacterial strains from species, such as

Indexed as

AMP-activated protein kinaseglycangut microbiotamacrophagemedicationprimary hypertension

Identifiers

PMID34803940
PMCPMC8600050
OpenAlexW3213993615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.